Current Medical Diagnosis & Treatment, 2006 (Current Medical Diagnosis and Treatment)

Tierney, Lawrence M., McPhee, Stephen J., Papadakis, Maxine A.

Current Medical Diagnosis & Treatment, 45th Edition

G

G6PD, deficiency of See Glucose-6-phosphate dehydrogenase deficiency

G_M1 ganglioside, for spinal trauma

1021

G20210A prothrombin mutation, in noncirrhotic portal hypertension

680

GABA See Gamma-aminobutyric acid

Gabapentin

984

for neuropathic pain/painful diabetic neuropathy

79

80

1223

for phobic disorder

1046

for seizures

983

984

GABHS See Group A beta-hemolytic streptococcal infection

GAD 65 antibodies, in type 1 diabetes

1195

1196

P.1798

Gait/gait disorders See also Falls

in elderly

60–62

61

screening for

51

52

53

in parkinsonism

1008

in spinal stenosis

820

in tabes dorsalis

1451

Galactomannan, in invasive aspergillosis

1544

Galactorrhea

1114

α-D-Galactosidase enzyme (Beano), for gastrointestinal gas

545

Galantamine, for dementia

1093

Galerina mushroom poisoning

1629

Gallaverdin phenomenon

333

Gallbladder

carcinoma of

692–693

cholesterolosis of

685

687

disorders of

in clonorchiasis/opisthorchiasis

1506

during pregnancy

685

782–783

gangrene of

687

hydrops of

687

porcelain

685

687

removal of See Cholecystectomy

stones in See Cholelithiasis

strawberry

687

Gallium nitrate

for cancer-related hypercalcemia

1691

for chemotherapy-induced toxicity/bone pain

1678

Gallium scanning

in infectious myocarditis

399

in tumor size evaluation

1686

Gallstone ileus

685

Gallstones See Cholelithiasis

Gambian trypanosomiasis

1463–1465

Gamete intrafallopian transfer (GIFT)

750

Gamma-aminobutyric acid (GABA), in Huntington's disease

1011

Gamma benzene hexachloride See Lindane

Gamma (γ) chain disease

798

Gamma globulin, intravenous See Intravenous immune globulin

Gamma-glutamyl transpeptidase (GGTP) levels

alcohol use/abuse and

1085

laboratory reference range for

1738

in liver disease/jaundice

650

Gamma-hydroxybutyrate, overdose/toxicity of

1625

Gamma-hydroxybutyrolactone, overdose/toxicity of

1625

Gamma interferon See Interferon-γ

Gamma knife radiation/gamma radiosurgery

1659

for acromegaly

1112

for intracranial arteriovenous malformations

998

for pituitary adenoma

1112

1115

1169

for thyroid cancer brain metastases

1127

for trigeminal neuralgia

979

Gammopathy

796–798

monoclonal

796

neuropathy associated with

1025

of unknown significance (MGUS)

516

797

polyclonal

796

Ganciclovir

1352

1588

cost of

1561

1562

for cytomegalovirus infection treatment/prophylaxis

168

176

1290

1335

1347

1352

1361

1588

prophylactic

1290

1588

therapy adjustments in renal or hepatic failure and

1558

Ganglioneuromas, in multiple endocrine neoplasia

1150

1192

Gangrene

bacterial synergistic

1435

of feet, in diabetes mellitus

1225

of gallbladder

687

gas

1408–1409

Ganja

1088

Gardnerella infection, vaginal

732

Garlic

1712

1714–1715

Gas

gastrointestinal

544–545

in urine (pneumaturia)

932

Gas gangrene

1408–1409

1553

Gasoline, sniffing

1090

Gastrectomy

for gastric cancer

598

hypoglycemia after

1234

1234

1238

vitamin B₁₂ deficiency and

487

Gastric acid/gastric contents

aspiration of See also Aspiration

acute (Mendelson's syndrome)

295

chronic

294–295

in comatose patient

1607

hospital-acquired pneumonia and

253

examination of in tuberculosis diagnosis

257–258

hypersecretion of, in Zollinger-Ellison syndrome/gastrinoma

595

1178

inhibition of secretion of See Acid-antisecretory agents; Antacids; H2 receptor blocking drugs; Proton pump inhibitors

radiation affecting secretion of

1600

reflux of See Gastric acid refluxate; Gastroesophageal reflux disease

Gastric acid refluxate See also Gastroesophageal reflux disease

abnormal clearance of

565–566

irritant effects of

565

Gastric anisakiasis

585

1516

Gastric bypass, for obesity

14

1099

1269

Gastric cancer

596–600

597

1664

adenocarcinoma

596–598

597

Helicobacter pylori infection and

584

597

1644

carcinoid tumors

599

dyspepsia in

536

597

Helicobacter pylori gastritis and

584

597

1644

lymphoma

598–599

Helicobacter pylori infection and

584

598–599

1644

mesenchymal tumors

599–600

peptic ulcer disease and

591

598

pernicious anemia gastritis and

585

upper gastrointestinal bleeding in

552

597

Gastric emptying, delayed, in gastroesophageal reflux disease

566

Gastric emptying study, in chronic intestinal pseudo-obstruction/gastroparesis

609

Gastric intubation, in corrosive acid/alkali ingestion

1617

Gastric lavage, for poisoning/drug overdose

1611–1612

Gastric mucosal biopsy, in gastric adenocarcinoma

597

598

Gastric neoplasms See Gastric cancer; Stomach disorders, tumors

Gastric outlet obstruction

in peptic ulcer disease

594

vomiting and

538

539

Gastric pH

nosocomial pneumonia and

253

in Zollinger Ellison/gastrinoma

595

Gastric polyps

596

Gastric ulcers

74

586

587

malignant

591

598

refractory

591

Gastric varices, gastrointestinal bleeding from

551–552

in noncirrhotic portal hypertension

680

Gastrin

D cells secreting

1178

hypersecretion of in pernicious anemia gastritis

585

in Zollinger-Ellison syndrome/gastrinoma

595

596

1178

laboratory reference range (normal values) for

1738

proton pump inhibitors affecting

588

Gastrinoma (Zollinger-Ellison syndrome)

595–596

1178

carcinoid tumors and

599

in multiple endocrine neoplasia

595

596

1178

1191

peptic ulcer disease and

591

595

1178

perforation and

593

Gastritis

582–600

alcoholic

583

atrophic

Helicobacter pylori infection and

584

in pernicious anemia

487

585

eosinophilic

585

erosive/hemorrhagic

582–584

gastrointestinal bleeding and

552

582

granulomatous

585

Helicobacter pylori

584–585

gastric cancer and

584

594

1644

lymphocytic

585

nonerosive/nonspecific

584–585

NSAID

583

in pernicious anemia

487

585

phlegmonous/necrotizing

585

stress

583

gastrointestinal bleeding and

552

583

in respiratory failure

309

583

Gastroduodenal surgery, antibiotic prophylaxis for

47

Gastroenteritis

545

1556

adenovirus causing

1299

1387

amebic

545

546

549

550

1299

1467–1472

1471

1556

Bacillus cereus causing

545

1300

1302

campylobacter

545

1299

1300

1301

1302

1428–1429

1556

Guillain-Barr syndrome and

1027

clostridial

545

546

coccidial and microsporidial

1475–1478

eosinophilic, dog hookworm causing

1526

Escherichia coli causing

545

546

1299

1300

1302

1427

irritable bowel syndrome and

615–617

in measles

1363

salmonella causing

545

1300

1301

1303

1426

1556

shigella causing (shigellosis)

545

1299

1300

1301

1303

1426–1427

1556

staphylococcal

545

viral

545

1299

1389

Yersinia enterocolitica causing

545

546

1299

1303

Gastroesophageal junction

stricture at See Esophagus, strictures of

tear at See Mallory-Weiss syndrome

P.1799

Gastroesophageal reflux disease

565–570

Barrett's esophagus and

566–567

chest pain in

566

581

chronic gastric aspiration and

294

cough and

21

22

219

566

dyspepsia in

536

heartburn in

564

hoarseness and

210

peptic stricture and

567

Gastrointestinal bleeding

551–558

acute

lower

554–557

upper

551–552

anorectal disease causing

554

555

aspirin and

556

in cirrhosis

574

670

diverticular

554

555

556

633

in erosive/hemorrhagic gastritis

552

582

from gastrointestinal/esophageal varices

551–552

573–576

in noncirrhotic portal hypertension

680

hemorrhoids causing

555

iron deficiency and

482

557

Mallory-Weiss syndrome and

552

572

NSAIDS and

74

556

830

obscure

557–558

occult

557–558

stool test for See Fecal occult blood testing

in peptic ulcer disease

551

592–593

in portal hypertension

551–552

in portal hypertensive gastropathy

552

583

risk assessment in patients with

553

in stress gastritis

552

583

in typhoid fever

1425

from vascular ectasias

552

554–555

Gastrointestinal fluid losses, replacement guidelines for

894

895

Gastrointestinal gas

544–545

Gastrointestinal irritant-type mushroom poisoning

1629

1630

1630

Gastrointestinal stromal tumor (GIST)

chemotherapy for

1669

of small intestine

benign

610

malignant

612

of stomach

599

Gastrointestinal system

536–548

decontamination of, in poisoning/drug overdose

1607

1611–1613

disorders of

536–558

in anisakiasis

585

1516

in anthrax

1412

1413

in ascariasis

1518

cancer, paraneoplastic syndromes associated with

1696–1697

chemotherapy-induced

1683

cytomegalovirus infection and

1360–1361

in fasciolopsiasis

1504–1505

functional

dyspepsia (nonulcer dyspepsia)

536

537–538

irritable bowel syndrome

615–618

noncardiac chest pain and

344

581–582

in HIV infection/AIDS

1326–1327

in hyperoxaluric calcium nephrolithiasis

946

motility See Motility disorders

mushroom poisoning causing

1629

1630

1630

radiation causing

1600

1683

in schistosomiasis

1501

1502

in scleroderma

838

839

in strongyloidiasis

1530

in syphilis

1450

tetracycline causing

1571

in trichinosis

1532

1533

in trichuriasis/whipworm

1533

Gastroparesis

609–610

in diabetics

609

1224

dyspepsia in

536

vomiting and

538

Gastropathy

582–600

erosive/hemorrhagic

582–584

gastrointestinal bleeding and

552

582

in HIV infection/AIDS

1327

hypertrophic (M n trier's disease)

585

portal hypertensive

583

gastrointestinal bleeding in

552

583

Gastroscopy, in anisakiasis

1516

Gastrostomies

1280–1281

Gatifloxacin

1579

1580

1580

1581

cost of

1561

1562

ophthalmic

175

Gaucher cells

1706

Gaucher's disease

1705–1706

Gaze-evoked nystagmus

152

GBE See Ginkgo biloba

GBL (gamma-hydroxybutyrolactone), overdose/toxicity of

1625

GBM antibodies See Anti-glomerular basement membrane antibodies

GBP See Gastric bypass

G-CSF (granulocyte colony-stimulating factor) See Filgrastim

Gefitinib

1669–1670

1676

1699

Gellhorn pessary, for uterine prolapse

741

Gemcitabine

1666

1675

Gemfibrozil

341

1250

1251

Gemifloxacin

1580

1580

1581

cost of

1562

therapy adjustments in renal or hepatic failure and

1558

1580

Gemtuzumab ozogamicin

1668

1676

Gender, cancer incidence/risk/mortality and

1639–1640

1640

Gender identity disorder (gender dysphoria)

1053

Gene expression analysis, in cancer

1642

treatment targeting and

1642

Gene probes See Nucleic acid probes

Gene therapy, for cancer

1700–1701

General well-being, evaluation of cancer treatment response and

1688–1689

Generalized anxiety disorder

1043

Generalized seizures

981–982

981

982–983

984

Genetic counseling See also Genetic testing; Prenatal testing

cancer screening and

1643

prenatal testing and

765

Genetic disorders

1703–1708

Genetic instability, in hereditary nonpolyposis colorectal cancer (HNPCC)

636–637

1643

Genetic testing See also specific disorder and Prenatal testing

for cancer susceptibility genes

1643

APC gene mutation

635

637

1643

breast cancer and

706

1643

colorectal cancer and

635

636

636–637

637

642

1643

hereditary nonpolyposis colorectal cancer and

636–637

1643

MYH gene mutation

635

for familial Mediterranean fever

563

for hemochromatosis

677

for Huntington's disease

1011

Genistein, in cancer prevention

1653

Genital herpes

108–109

1350

during pregnancy/neonatal infection

778–779

1351

1353

Genital prolapse

741

Genital reconstruction surgery, for transsexuals

1053

1054

Genital ulcers

adenovirus causing

1387

in Beh et's syndrome

851

in chancroid

1433

in granuloma inguinale

1433

herpetic See Genital herpes

in lymphogranuloma venereum

1440

Genital warts See Venereal (genital) warts

Genitourinary system See also specific organ or structure

disorders of

931–973

benign prostatic hyperplasia

954–961

956

958

959

hematuria in

931–932

935–936

history in

931–932

infections

936–943

939

irritative voiding symptoms in

932

male erectile and sexual dysfunction

950–954

malignant

961–973

obstructive voiding symptoms in

932

pain in

931

physical examination in

933–934

in schistosomiasis

1501

1502

systemic manifestations of

932

ulcers See Genital ulcers

urinalysis in

934–935

urinary incontinence

62–64

62

932

947–950

urinary stone disease

943–947

944

evaluation of

931–935

Genomic hybridization, comparative, cancer development studied with

1641

Genotypic resistance testing, in antiretroviral therapy

1344–1345

1344

1345

Genotyping, cancer treatment and

1642

Gentamicin

1572

1572

1574

for anaerobic intra-abdominal infections

1435

cost of

1561

for endocarditis prophylaxis

1417

1418

1418

for hair cell destruction in vertigo

193

monitoring concentrations of

1734

for ophthalmic disorders

175

resistance to

1574

therapy adjustments in renal failure and

1572

1573

for urinary tract infections

939

Geodon See Ziprasidone

GERD See Gastroesophageal reflux disease

Geriatric Depression Scale

53

Geriatric medicine

49–66

approach to older patient and

49–55

50

51

assessment of elderly and

50–54

53

54

common problems in frail elderly and

55–66

general principles of

49

preventive care and

54–55

psychiatric disorders and

1094–1095

P.1800

Geriatric screen

50

51

Germ cell tumors, testicular

971–973

1182

Germline testing, in hereditary nonpolyposis colorectal cancer

636–637

1643

Gerstmann-Str ussler-Scheinker disease

1375

Gerstmann's syndrome

1001

Gestational diabetes

776–777

777

screening for

765

777

Gestational hyperthyroidism See Hyperthyroidism (thyrotoxicosis), during pregnancy

Gestational trophoblastic disease

773–774

1665

hyperthyroidism in

774

paraneoplastic syndromes associated with

1696–1697

Gestodene, in oral contraceptives, thromboembolism and

753

GFR See Glomerular filtration rate

GGTP levels See Gamma-glutamyl transpeptidase (GGTP) levels

GH See Growth hormone

GHB (gamma hydroxybutyrate), overdose/toxicity of

1625

Ghon complex, in tuberculosis

258

Ghrelin, in obesity

1098

Giant cell (temporal/cranial) arteritis

846–847

headache in

846

977

optic neuropathy and

169

846

retinal artery occlusion and

166

Giant cell myocarditis

399

Giant cell thyroiditis See Subacute (de Quervain's) thyroiditis

Giant cell tumor of bone (osteoclastoma)

862

Giant congenital melanocytic nevi

93

Giardia antigen assay, stool

546

550

1479

Giardia lamblia/intestinalis/duodenalis (giardiasis)

545

546

549

550

1299

1301

1478–1480

GIFT See Gamete intrafallopian transfer

Gigantism

1110–1112

Gilbert's syndrome

649

651

Gilles de la Tourette's syndrome

1013–1014

Gingivitis

in HIV infection/AIDS

1326

necrotizing ulcerative

204

Gingivostomatitis See also Gingivitis; Stomatitis

herpetic

108

204

Ginkgo biloba

1712

1715–1716

for dementia

57

1712

1715

for lower extremity occlusive disease

454

1715

Ginseng

1712

1717–1718

GIST See Gastrointestinal stromal tumor

Gitelman's syndrome

874

Glanders

1553

Glanzmann's thrombasthenia

523

525

Glaucoma

acute angle-closure

151

159–160

inflammation/redness caused by

151

153

159

pupillary dilation precipitating

153

159

177

chronic

160–162

in diabetes mellitus

1221

drug therapy for

161

173–174

in elderly

65

facial pain caused by

979

neovascular (rubeotic), retinal vein occlusion and

165

normal-tension

160

161

Gleason grading system, for prostate cancer

964

Gleevec See Imatinib mesylate

Gliadin, in celiac disease

601

602

Gliclazide

1207

1209

Glimepiride

1207

1209

Glioblastoma multiforme

1000

Gliomas

999

brain stem

1000

1001

spinal

1003

Gliosis, in multiple sclerosis

1014

Glipizide

1207

1209

intensive therapy with

1203–1205

Globin chain synthesis, in thalassemias

484

α-Globin gene

484

484

in alpha thalassemia syndromes

484

484

β-Globin gene

484

484

in beta thalassemia syndromes

484

484

in sickle cell syndromes

493

Glomerular filtration rate

898–899

898

899

aging affecting

930

alkalosis in alkali administration and

892

in diabetic nephropathy

923

hypotonic hyponatremia and

867

in prerenal azotemia

902

radionuclide studies in evaluation of

899

in renal failure

907

907

Glomerular proteinuria

897

Glomerular sclerosis/glomerulosclerosis

in diabetic nephropathy

923

focal segmental

920

922

in systemic lupus erythematosus

924

Glomerulonephritis

901

905–906

916

917

acute renal failure caused by

901

905–906

anti-glomerular basement membrane (anti-GBM)

905

916

918–919

cryoglobulin-associated

850

916

919

in Goodpasture's syndrome

293

916

918–919

HLA in

801

IgA nephropathy (Berger's disease)

915–917

916

917

immune-complex

905

membranoproliferative

916

920

924–925

hepatitis C infection and

655

924

in microscopic polyangiitis

849

916

nephritic presentation of

914–915

916

917

nephrotic presentation of

914

919–921

920

pauci-immune (ANCA-associated)

799

905

905–906

916

918

peri-infectious

915

916

postinfectious

915

916

917

1400

rapidly progressive

914–915

917

in systemic lupus erythematosus

835

916

924

in Wegener's granulomatosis

848

916

Glomerulonephropathies

914–921

coxsackievirus infection and

1390

membranoproliferative

916

920

924–925

hepatitis C infection and

655

924

sickle cell

929–930

Glomerulosclerosis See Glomerular sclerosis/glomerulosclerosis

Glomus tumors (tympanicum/jugulare)

187

Glossitis

203–204

Glossodynia

203–204

Glossopharyngeal neuralgia

979

earache in

187

headache in

974

Glottic (true vocal cord) cancer (TVC)

211

212

212

GLP-1 See Glucagon-like peptide 1

Glucagon

A cells secreting

1178

for beta-adrenergic blocker overdose/toxicity

1620

for insulin reaction

1220

in insulinoma diagnosis/treatment

1236

1237

lack of response to, hypoglycemia in type 1 diabetics caused by

1220

Glucagon-like peptide 1 (GLP-1), for diabetes mellitus

1212

Glucagonomas

1178

1191

β-Glucocerebrosidase, in Gaucher's disease

1705

1706

Glucocorticoid-remediable hyperaldosteronism

874

Glucocorticoids

1192–1193

clinical use of

1192–1193

1193

Cushing's syndrome caused by

1167

deficiency of See also Adrenocortical insufficiency

familial

1165

perioperative administration of

46

for prostate cancer

966

Glucokinase gene defect, in maturity-onset diabetes of young (MODY)

1197

Glucometers, for self-monitoring blood glucose

1200

Glucophage See Metformin

Glucosamine sulfate plus chondroitin

810

1721–1722

1721

Glucose See also Glucose tolerance/intolerance

ascitic fluid

560

561

blood levels of See also Hyperglycemia; Hypoglycemia

in diabetes mellitus

1217

continuous monitoring of

1200–1201

control of See Glycemic control in diabetes

pregnancy and

776

777

self-monitoring of

1200

1217

surgery and

45–46

45

in diabetic coma

1228

1228

in diabetic ketoacidosis

1228–1229

1228

in hyperglycemic hyperosmolar state

1228

1231

1232

in insulinoma

1235

laboratory reference range (normal values) for

1738

monitoring/management of during surgery

45–46

45

prebreakfast hyperglycemia and

1218–1219

1219

testing

1199

1199

in pregnancy

765

777

cerebrospinal fluid, in CNS infection

1294

in diabetic ketoacidosis management

1230

drugs affecting absorption of

1208

1211

for hyperkalemia

876

877

hyperosmolality caused by

872

for hypoglycemia

1220

in hypoglycemia

1233

intraoperative administration of

45

joint fluid

807

808

pleural fluid

301

in urine See Glycosuria

Glucose-dependent insulinotropic polypeptide 1 (GIP1), in diabetes mellitus

1212

Glucose-6-phosphate dehydrogenase

491

Glucose-6-phosphate dehydrogenase deficiency

492

chloroquine therapy and

1492

dapsone therapy and

1347

primaquine therapy and

1494

sulfasalazine therapy and

832

P.1801

Glucose-6-phosphate dehydrogenase screen, laboratory reference range for

1738

Glucose tolerance/intolerance See also Diabetes mellitus

in Cushing's syndrome

1168

in diabetes mellitus

1199

1199

functional hypoglycemia and

1238

laboratory reference range (normal values) for

1199

1738

lithium affecting

1076

in pancreatic and periampullary carcinoma

700

in pregnancy

776

in renal failure

911

testing

1199

1199

in pregnancy

765

777

Glucose toxicity, in type 2 diabetes

1196

Glucose transporters, thiazolidinediones affecting expression of

1210

a-Glucosidase inhibitors, for diabetes mellitus

1208

1211

Glucosuria See Glycosuria

Glucotrol See Glipizide

Glucovance See Glyburide, with metformin

GLUT 1/GLUT 4 See Glucose transporters

Glutamic acid decarboxylase antibodies, in type 1 diabetes

1195

1196

Glutamine, laboratory reference range for

1738

g-Glutamyl transpeptidase (GGTP) levels

alcohol use/abuse and

1085

laboratory reference range for

1738

in liver disease/jaundice

650

Glutathione reductase, in riboflavin deficiency

1273

Gluten enteropathy (celiac disease/sprue) See Celiac disease

Gluten-free diet, for celiac disease/dermatitis herpetiformis

113

601

603

Glyburide

1207–1209

1207

intensive therapy with

1203–1205

with metformin

1208

1211

Glycated (glycosylated) hemoglobin See Hemoglobin A₁/A_1a/A_1b/A_1c

Glycemic control in diabetes

acceptable levels of

1219–1220

complications rate and, clinical studies of

1202

1203–1205

glycated hemoglobin (hemoglobin A₁) measurements in evaluation of

1199–1200

1202

1203

1204

1205

1218

1220

nephropathy development/progression and

923

1202

1204

1222

pregnancy and

776

777

retinopathy development/progression and

167

1202

1204

self-monitoring of blood glucose and

1200

1217

surgery and

45–46

45

Glycogen storage disease, hepatic adenomas in

683

Glycohemoglobins See Hemoglobin A₁/A_1a/A_1b/A_1c

Glycoprotein Ib receptor, in hemostasis

523

in Bernard-Soulier syndrome

523

525

Glycoprotein IIb/IIIa receptors

drugs blocking

for acute coronary syndromes

352

353

for myocardial infarction

353

with PTCA/stenting

350

351

353

in hemostasis

523

Glanzmann's thrombasthenia and

523

525

Glycosuria/glucosuria

934

in diabetes mellitus

1198

1199

ketoacidosis and

1228

1228

in diabetic coma

1228

1228

hypernatremia and

871

nondiabetic (renal)

1201

in pancreatic and periampullary carcinoma

700

in pregnancy

1201

Glycosylated (glycated) hemoglobin (hemoglobin A₁) See Hemoglobin A₁/A_1a/A_1b/A_1c

Glycosylphosphatidylinositol (GPI) anchor deficiency, in paroxysmal nocturnal hemoglobinuria

491

Glynase See Glyburide

Glyset See Miglitol

G_M1 ganglioside, for spinal trauma

1021

GM-CSF (granulocyte macrophage colony-stimulating factor) See Sargramostim

Gnathostoma spinigerum (gnathostomiasis)

1524

GnRH analogs See Gonadotropin-releasing hormone (GnRH) analogs

Goeckerman regimen, for psoriasis

98

Goiter

1119–1122

1120

endemic

1130–1131

hyperthyroidism and

1130

1131

1137

hypothyroidism/cretinism and

1130

1131

lithium causing

1076

multinodular (nodular)

1120

1122

toxic

1140–1141

substernal

1130

Gold therapy

adverse ocular effects of

179

breast feeding and

785

Goldie-Coldman hypothesis

1660

Golf elbow

824

GoLYTELY See Polyethylene glycol

Gonadal dysgenesis (Turner's syndrome)

1189–1190

1190

amenorrhea caused by

1183

1184

1189

thyroiditis and

1144

Gonadoblastoma, testicular

971

Gonadotropin-releasing hormone (GnRH)

deficiency of, in amenorrhea

1183

1184

for ovulation induction

750

Gonadotropin-releasing hormone (GnRH) analogs See also Luteinizing hormone-releasing hormone (LHRH) analogs

for cancer chemotherapy

1674

for endometriosis

740

hypogonadotropic hypogonadism and

1106

Gonadotropins

cancer-related production of

1696

deficiency of

1104–1105

in amenorrhea

1183

human chorionic (hCG) See Human chorionic gonadotropin

human menopausal (hMG), for ovulation induction

750

Gonococcal infections/gonorrhea

1431–1433

1552

anorectal involvement and

645

1431

1432

arthritis and

856–857

1432

cervicitis

1432

chlamydial coinfection and

1432

1441

conjunctivitis

156

1432

disseminated

1432

drug resistant

1432

epididymitis in

943

1431

1556

pelvic inflammatory disease

741

742

1432

1433

1557

pharyngitis

1432

during pregnancy

780

rape/sexual assault in transmission of

759

1297

urethritis

1431–1432

1432

1556

Goodpasture's syndrome

293

918–919

glomerulonephritis in

293

905

906

916

918–919

HLA in

801

918

Gordon syndrome (pseudohypoaldosteronism type II)

874

Goserelin

1674

GOT See Aspartate aminotransferase

Gottron's sign

840

Gout/gouty arthritis

810–814

811

813

renal manifestations of

811

930

rheumatoid arthritis differentiated from

812

828

saturnine, in lead poisoning

812

926

in transplant patient

814

gp120/160, HIV vaccine development and

1331

GPI (glycosylphosphatidylinositol) anchor deficiency, in paroxysmal nocturnal hemoglobinuria

491

GPT See Alanine aminotransferase

GRACE Risk Score

354

Gradenigo's syndrome

186

Graft-versus-host disease, in HPC transplantation

803

immunosuppressive therapy and

804

Graft-versus-leukemia effect

506

Graft-versus-tumor effect

1661

Graham–Steel murmur

338

Gram-negative infections

1420–1436

1552–1553

bacteremia and sepsis

1423–1424

endocarditis and

1415

folliculitis, acne and

116

118

Gram-positive infections

1400–1414

1552

1553

Gram stain

ascitic fluid

560

in pneumonia diagnosis

251

Grand mal (tonic-clonic) seizures

981–982

981

984

Grand mal (tonic-clonic) status epilepticus

986

Granisetron

540

540

1682

Granular urinary casts

896

897

935

Granulocyte colony-stimulating factor (G-CSF) See Filgrastim

Granulocyte macrophage colony-stimulating factor (GM-CSF) See Sargramostim

Granulocyte transfusion

535

Granulocytic ehrlichiosis/anaplasmosis

1392

1397

Granulocytopenia See also Neutropenia

infections and

1288–1289

Granuloma See also Granulomatosis; Granulomatous disorders

hepatic, drugs/toxins causing

666

inguinale

1433

intubation

210

lethal midline

201

pulmonary, in sarcoidosis

279

swimming pool

1438

P.1802

Granulomatosis

allergic angiitis and See Allergic angiitis and granulomatosis

infantisepticum

1414

Wegener's See Wegener's granulomatosis

Granulomatous disorders See also specific type and Granuloma; Granulomatosis

acanthamoeba causing

1473

gastritis in

585

hypercalcemia in

1152

neck involved in

215–216

of nose and paranasal sinuses

200–202

Granulomatous thyroiditis See Subacute (de Quervain's) thyroiditis

Granulosa cell tumor

745

Graves' dermopathy (pretibial myxedema)

1135

1137

1142

Graves' disease

1135

1138–1140

HLA in

801

1135

thyroid antibodies/TSH receptor antibody in

1118–1119

1135

Graves' ophthalmopathy/exophthalmos (dysthyroid eye disease)

170

1135

1137

1140

1141

Gray top tubes

1743

Great toe, in gout

811

Green poultice, chronic pain disorders and

1050

Green top tubes

1743

Grief reaction/grieving

85

1065–1066

Grippe, summer

1389

Griseofulvin

101

Ground itch, in hookworm disease

1525

Group A beta-hemolytic streptococcal infection

1401–1402

1552

cellulitis

125

1556

endocarditis

1402

1418

erysipelas

124

1401

1556

glomerulonephritis and

915

1400

impetigo

113

1401

1556

pharyngitis

204–206

1400–1401

1556

rapid antigen tests for

205

1400

1401

rheumatic fever and

405

1400

1401

scarlet fever

1400

1402

skin infections

1401

Group B streptococcal infection

1402

1552

endocarditis

1418

in pregnancy

766

780

1402

Group C streptococcal infection

1552

endocarditis

1418

Group D streptococcal infection

1402

endocarditis

1402

1415

Group G streptococcal infection

1552

endocarditis

1418

Group therapy See also Support groups

for anxiety disorders

1047

for chronic pain disorders

1052

for personality disorders

1055

for somatoform disorders

1049

Growth factors See also Filgrastim; Sargramostim

in cancer chemotherapy

1669

for chemotherapy-induced toxicity

1671

1680

for HIV infection/AIDS

1346

for infection in cancer/immunocompromised host

1291

1694

for neutropenia

499

platelet-derived, in myelofibrosis

503

receptors for, blockade of in cancer treatment

1698

1698

Growth hormone (GH)

deficiency of

1105

1106

1107

obesity and

1099

excess of, acromegaly and gigantism caused by

1110–1112

in phosphate metabolism

800

replacement therapy with

1107

for AIDS wasting

1322

for Turner's syndrome

1189

serum levels of

in acromegaly/gigantism

1111

laboratory reference range for

1739

tumors secreting

1106

1191

Guaiac testing See Fecal occult blood testing

Guanabenz

437

438

overdose/toxicity of

1622–1623

Guanadrel

437

Guanethidine

437

antidepressant drug interactions and

1074

monoamine oxidase inhibitor interactions and

1074

Guanfacine

437

438

overdose/toxicity of

1622–1623

Guillain-Barr syndrome (acute idiopathic polyneuropathy)

1026–1027

1367

dysautonomia in

987

1027

influenza vaccination and

1310

1383

Guinea worm infection (dracunculiasis)

1520–1521

Gum disease See Gingivitis

Gummas, in syphilis

1443

1444

1448

1450

Guns See Firearms

Gut See Gastrointestinal system

Gut dialysis, (repeat-dose charcoal)

1613

Guttate psoriasis

97

GW572016 See Lapatanib

Gynecologic disorders

728–762

diagnostic procedures used in

729

in HIV infection/AIDS

1329

Gynecomastia

1100–1101

1101

in hypogonadism

1180

1181

in Klinefelter's syndrome

1180

1707

testicular tumors causing

972

1182

1183

Gypsy moths, skin lesions caused by

136

Gyromitra (monomethylhydrazine) mushroom poisoning

1629

1630

1630